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Oxygen uptake efficiency slope is not a valid 
submaximal measure of aerobic capacity  
in paediatric cystic fibrosis patients 
Introduction 
 
• Patients with cystic fibrosis (CF) with higher maximal oxygen consumption   
(VO2 peak) have significantly higher survival rates.1 
  
• Aerobic fitness testing based on maximal effort - patients with CF may be 
unable or unwilling  to reach volitional exhaustion - submaximal measures could 
be more practical.2 
  
• Oxygen uptake efficiency slope (OUES) is a submaximal parameter showing 
the relationship between oxygen uptake (VO2) and the common logarithm of 
minute ventilation (Log VE)3 
  
• OUES at 80% duration is valid in adults with CF4 but not in a paediatric 
population as only moderately correlated with VO2 peak5   
• Standardisation of OUES to %duration of the test is flawed as not  
representative of each individual’s exercise intensity relative to their metabolic 
boundaries. 
  
• Oxygen uptake efficiency (OUE) is the ratio of VO2 to VE6 other submaximal 
indicators include gaseous exchange  threshold (GET), respiratory 
compensation point (RCP) and the plateau of highest consecutive values 
(OUEP).  
  
The aim of the study was to investigate the validity of   
submaximal exercise measures in the paediatric CF patients.  
Methods 
 
• Cardiopulmonary exercise test (CPET) data collected from 79 patients with CF 
and 31 healthy controls (13.1 ± 2.9 y , 156.0 ± 14.7 cm, 50.6 ±16.2 kg) was 
retrospectively analysed. 
 
• OUE was determined at GET and RCP using a 60 s average, and OUEP with a 
90 s average. Six of the 79 patients with CF did not have a detectable GET so 
were not included in any further analyses. 
 
• OUES was calculated at 50%, 75% and 100% of test duration and VO2 peak, GET 
and RCP. Values standardised for body surface area (BSA).  
 
• Pearson’s correlation coefficient was calculated between OUES/BSA measures 
and VO2 peak relative to body mass (mL.kg-1.min-1), and independent t-tests were 
conducted between CF and healthy groups. 
Results 
  
• Descriptive statistics for participants included in the study are shown in Table 1. 
  
Table 1. Characteristics of 104 subjects (mean ± SD)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      BMI= body mass index; BSA= body surface area; FVC= Forced vital capacity; FEV1= Forced expiratory volume in 1 s 
 
• VO2 peak (mL.kg-1.min-1) and OUE/BSA at GET, RCP and plateau were 
significantly lower in adolescents with CF than healthy adolescents (Table 2). 
 
Table 2. CPET Exercise Variables (mean ± SD) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           WR=work rate, HR= heart rate, RER= respiratory exchange threshold;  * p< 0.05 
Results 
 
• Significant moderate correlations between OUES/BSA and peak VO2 adjusted 
to body mass for  adolescents with CF and healthy controls, at all intensities, 
durations and thresholds (p< 0.01), shown in Table 3. Correlations were 
moderate (0.332 - 0.601) in adolescents with CF, but moderate to strong in 
healthy adolescents (0.497 - 0.800).  
 
Table 3. Correlations between OUES/BSA and Peak VO2 (mL.kg-1.min-1) at the 
different thresholds 
 
 
 
 
 
 
 
 
 
                           ** p< 0.01 
 
 
• No significant difference in OUES/BSA between healthy adolescents and 
adolescents with CF at any of the thresholds of the CPET (see Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Comparison of OUES/BSA values between adolescents with CF and 
healthy adolescents at different exercise thresholds. 
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Adolescents with CF n=73 Healthy adolescents n=31 p-value 
Gender (m/f) 46/27 10/21 
Age (y)  13.16 ± 2.88 12.94 ± 3.02        p= 0.169 
Stature (cm) 156.0 ± 15.5     155.9 ± 13.1   p= 0.981 
Body mass (kg) 52.31 ± 17.55      46.58 ± 11.96      p= 0.100 
BMI (kg.m-2) 20.84 ± 3.72        18.83 ± 2.43 * p= 0.007 
BSA (m2) 1.50 ± 0.33          1.41 ± 0.24          p=0.193 
FVC 3.10 ± 1.17         n=72 
FVC % predicted 97.74 ± 16.82     n=71 
FEV1 2.80 ± 1.00         n=72 
FEV1 % predicted 95.10 ± 14.45     n=71 
OUES/BSA threshold CF Healthy 
50%VO2 peak 0.398** 0.497** 
75% VO2 peak 0.487** 0.710** 
100% 0.601** 0.800** 
GET 0.332** 0.524** 
RCP 0.557** 0.800** 
Discussion 
 
• Despite significant correlations between OUES/BSA and VO2 peak at all 
thresholds, OUES/BSA was not significantly different between healthy 
adolescents and those with CF at any threshold point, supporting Bongers et al.5 
that OUES is not a valid submaximal measure in adolescents with CF.  
 
• A novel finding was adolescents with CF had significantly lower values than 
healthy adolescents for OUE@GET/BSA, OUE@RCP/BSA and OUEP/BSA 
 
• GET occurred at 53% of VO2 peak in this sample of 73, so OUE at this threshold 
could be more representative of the individual’s ability to cope with sub-
threshold activity demands compared to exercise above the threshold point. 
 
• OUE & OUEP could provide alternative measure for adolescents unable to 
reach volitional maximum. 
  
Conclusion:  
OUES is not a valid submaximal measure of aerobic capacity in adolescents with 
CF, however OUE & OUEP as alternative measures should be investigated. 
 
Adolescents with CF n=73 Healthy adolescents n=31 p-value 
WRpeak (W) 162 ± 73               154 ± 60               p=0.522 
VO2peak (L.min-1) 1.86 ± 0.68           1.91 ± 0.82           p=0.748 
VO2peak (ml.kg-1.min-1) 37.03 ± 6.88         41.05 ± 10.55 * p=0.023 
GET (L.min-1) 0.96 ± 0.34           1.06 ± 0.47           p=0.295 
GET (%VO2peak) 53.27 ± 9.57         55.91 ± 7.37        p=0.133 
VEpeak 78.26 ± 33.81       60.42 ± 30.03  *     p=0.010 
OUE@GET/BSA 24.62 ± 6.73     n=72 31.60 ± 5.16 * p=0.000 
OUE@RCP/BSA 20.58 ± 5.86     n=72 26.07 ± 4.92 * n=27  p=0.000 
OUEP/BSA 25.25 ± 6.42         33.03 ± 6.16 * p=0.000 
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